{"id":1591,"date":"2026-03-31T10:50:27","date_gmt":"2026-03-31T10:50:27","guid":{"rendered":"http:\/\/206.189.58.239\/eu\/about-us\/"},"modified":"2026-04-21T13:15:11","modified_gmt":"2026-04-21T13:15:11","slug":"about-us","status":"publish","type":"page","link":"https:\/\/zurimed.com\/eu\/about-us\/","title":{"rendered":"About Us"},"content":{"rendered":"\n
\n\t\t\t
\n\t\t\t\"\"\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\n\t
\n\t\t\t\t\t

About Us<\/h1>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\n\n
\n
Team<\/a><\/div>\n\n\n\n
Careers<\/a><\/div>\n\n\n\n
Get to Know Us<\/a><\/div>\n\n\n\n
History<\/a><\/div>\n<\/div>\n\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n

The Team<\/h2>\n\n\n\n

The core of ZuriMED is built by its people. Our interdisciplinary and diverse team is backed by a strong board of directors comprised of world-renowned experts. Together, we aim to push the boundaries of current orthopedic and sports medicine solutions through our innovative technologies.<\/p>\n\n\n\n\t

\n\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Xiang\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Xiang holds a Dr. sc. ETH Zurich degree in Orthopaedic Biomechanics and has over 15 years of experience in medical engineering. Alongside business development, he has built strong expertise in finance, legal, quality, and management. With a clear vision and entrepreneurial mindset, he leads operations, fosters an engaging work environment, and motivates the team to drive innovation and create value.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Xiang Li<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

CEO & Co-Founder<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Elias\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

After completing his biomedical engineering studies, Elias spent several years as a research fellow at the Laboratory of Orthopaedic Biomechanics, Balgrist University Hospital, and ETH Zurich. His journey led him to co-found ZuriMED Technologies AG, where he is now responsible for the technical direction, strategy and development.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Elias Bachmann<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

CTO & Co-Founder<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Pol\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

With a background in Mechanical Engineering, Pol spent time at Harvard\u2019s Biodesign Lab and at ETH\u2019s Computational Robotics Laboratory before joining ZuriMED early in 2020. He now leads industrialization and lifecycle management, overseeing the transition to scalable manufacturing, ensuring robust manufacturing processes and continuous improvement of medical devices from market launch onward.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Pol Banzet<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Chief Production Officer<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Sascha\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sascha holds an MSc in Mechanical Engineering, specializing in Robotics and Mechatronics, from ETH Zurich. He leads the development of powered devices at ZuriMED. After a traineeship at the Helbling Robotics Team and a research assistant position at the biomechanics lab, Sascha joined ZuriMED from the early days on.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Sascha Brun<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Head of Development<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Andrea\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Andrea, Head of Clinical Affairs, holds an MSc in Health Science and Technology from ETH Zurich. She leads pre-clinical and clinical studies, playing a pivotal role in clinical evaluation processes. After a traineeship at DePuy Synthes and a research internship in the rehabilitation engineering field, Andrea joined ZuriMED for her master\u2019s thesis and supported the Surgical-Fiberlock technology project from its early stages.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Andrea M\u00f6hl<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Head of Clinical Affairs<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\"Sebastian\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sebastian leads ZuriMED's quality and regulatory compliance department. Backed by more than six years of experience in Medtech and a certification as a lead auditor, Sebastian is instrumental in ensuring that all compliance measures and quality standards are met, upholding and advancing the company's commitment to quality, compliance, and continuous improvement.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t

\n\t\t\t\t\t\t

Sebastian Arevalo<\/h3>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t

Head of Quality<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/svg>\n\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\tShow all Team Members<\/span>\n\t\t\t\t\t\t\u25bc<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\n\n\n\n
<\/div>\n\n\n\n

Our Board of Directors is comprised of world-leading scientists, consultants and clinicians supporting the company in their field of expertise.<\/p>\n\n\n\n

\n
\n

Prof. Dr. Jess Snedeker<\/h4>\n\n\n\n

President of the Board of Directors<\/p>\n\n\n\n

Ulrich Looser<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n\n\n\n

Tyler Beeson<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n<\/div>\n\n\n\n

\n

Dr. med. Dominique Tschudi<\/h4>\n\n\n\n

Vice President of the Board of Directors<\/p>\n\n\n\n

Dr. Helen (Ying) Yang<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n\n\n\n

Dr. Xiang Li<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n<\/div>\n\n\n\n

\n

Prof. Dr. Robert Frigg<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n\n\n\n

Chan-Yuan Lu<\/h4>\n\n\n\n

Member of the Board of Directors<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Join the Team!<\/h2>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n \n
\n

\n Junior Event & Administration Manager <\/h3>\n \n
\n We are seeking a proactive and highly organized Accounting Associate. <\/div>\n \n
\n \n Active <\/span>\n \n \n <\/span>\n Download PDF <\/a>\n <\/div>\n <\/div>\n <\/article>\n
\n \n
\n

\n Junior Lifecycle Engineer <\/h3>\n \n
\n We are looking for a highly motivated and dynamic junior lifecycle engineer to join our industrialization and lifecycle team. <\/div>\n \n
\n \n Active <\/span>\n \n \n <\/span>\n Download PDF <\/a>\n <\/div>\n <\/div>\n <\/article>\n <\/div>\n <\/div>\n\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n\t\t\t

Get to Know Us<\/h2>\n\t\n\t
\n\t\t\n\n
\n\t\n\t
\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

ZuriMED originated in Zurich, Switzerland, and is part of the Swiss health cluster. Surrounded by world-leading universities and orthopedic healthcare institutes, we have unique access to high-quality labs, clinical knowledge, and exceptionally skilled talents.<\/p>

The startup spun off from the University of Zurich and ETH Zurich in 2015 and is supported by Balgrist Beteiligungs AG. With this, we benefit from a close collaboration with research groups and clinicians, accelerating the transition from bench to bedside.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\t\t

\n\t\t\tOur Values\t\t<\/h3>\n\t<\/div>\n\n\n\n
\n\t\t\t
\n\t\t\t\n\t\t<\/div>\n\t\n\t
\n\t\t\t\t\t

Innovation<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

We embrace creativity and entrepreneurial thinking, developing groundbreaking technologies to pioneer advancements and reshape the future of healthcare.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\t\t
\n\t\t\t\n\t\t<\/div>\n\t\n\t
\n\t\t\t\t\t

Ambition<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

Our relentless pursuit of excellence and our vision of improving patients\u2019 lives drive us to set new benchmarks in the industry.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\t\t
\n\t\t\t\n\t\t<\/div>\n\t\n\t
\n\t\t\t\t\t

Reliability<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

We are committed to creating a working environment where employees can trust each other while delivering high-quality products and services that healthcare professionals as well as patients can rely on.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\n\t
\n\t\t\t\t\t

Our Mission<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

ZuriMED strives to develop innovative technologies that overcome current limitations in soft tissue repair by leveraging our pragmatic, agile, and motivated team in close collaboration with healthcare professionals.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\n\t
\n\t\t\t\t\t

Our Vision<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

We envision a future where our products have redefined modern surgical practices to maximize the quality of physicians\u2019 treatment options and patients\u2019 lives.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\t\t

\n\t\t\tSustainability\t\t<\/h3>\n\t<\/div>\n\n\n\n
\n\t\n\t
\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

At ZuriMED, we are driven by the mission of sustainable innovation and guided by our vision for a better future \u2014 not only revolutionizing soft tissue repair in sports medicine but also fostering healthy competition in the MedTech industry while focusing on local environmental impact.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n

\n\t\n\t
\n\t\t\t\t\t

Our Sustainability Goal<\/h3>\n\t\t\n\t\t\t\t\t
\n\t\t\t\t

Creating a fair workspace where diversity and inclusion are embraced, while focusing on local initiatives and partnerships. We not only take the well-being of our patients and employees seriously but also uphold our responsibility to local communities.<\/p>\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\t<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n\t\t\n\t
<\/div>\n\t\n\t
\n\t\t\n\n

2025 | Market Launch<\/h4>
<\/span><\/div><\/div>

The 12th of February marks the day of the market entry of the FiberLocker System in the U.S. Since then, the reinforcement system is commercially available and can be used for rotator cuff augmentation in the clinical setting.

Furthermore, a first-in-human clinical study in Switzerland and a multicenter clinical study in the U.S. have been initiated.<\/br\\\\><\/p><\/div><\/div>\n\n\n\n

2024 | FiberLocker System receives FDA Clearance<\/h4>
<\/span><\/div><\/div>

In December 2024, ZuriMED Technologies AG celebrated a significant achievement: the FDA clearance of our 510(k) submission for the FiberLocker\u00ae System. This represents the first clinical indication of the pioneering Surgical-Fiberlock\u00ae technology. We anticipate a limited U.S. market release of the SpeedPatch\u00ae PET and FiberLocker\u00ae Instrument in early 2025, allowing patients to soon benefit from this new technology.<\/p><\/div><\/div>\n\n\n\n

2023 | ZuriMED closes Series-A financing round & receives Innosuisse Swiss Accelerator Grant<\/h4>
<\/span><\/div><\/div>

The financing round was led by Chindex Medical Limited (Hong Kong), followed by Yellowstone Holding AG (Geneva) and a group of private investors that includes leading orthopaedic surgeons from Switzerland, Germany, France, and the United States. An additional non-diluting funding from Innosuisse will greatly expedite the development and regulatory registration process of a second clinical indication.<\/p><\/div><\/div>\n\n\n\n

2022 | ZuriMED obtains Innosuisse Scale-up Award & Innosuisse Project Grant<\/h4>
<\/span><\/div><\/div>

Thanks to this award, ZuriMED can access the second phase of the Scale-up Coaching program to further accelerate the growth in Switzerland and the expansion into new global markets. The Project Grant supports the co-development with research partner University Hospital Balgrist on ZuriMED\u2019s breakthrough technology for soft tissue repair.<\/p><\/div><\/div>\n\n\n\n

2021 | ISO 13485 certificate obtained<\/h4>
<\/span><\/div><\/div>

ZuriMED achieves ISO 13485 certification through BSI<\/p><\/div><\/div>\n\n\n\n

2020 | ZuriMED closes a license deal with an international medical device company<\/h4>
<\/span><\/div><\/div>

One of ZuriMED\u2019s endocortical fixation technologies for soft tissue repair has been licensed to an international medical device company. A strategic partnership has been established to work together to bring this technology to clinical applications.<\/p><\/div><\/div>\n\n\n\n

2019 | ZuriMED obtains the Innosuisse Certificate<\/h4>
<\/span><\/div><\/div>

The company has now obtained the Innosuisse certificate in recognition for the potential of its technology and solutions. The role of Innosuisse \u2013 the Swiss Innovation Agency \u2013 is to promote science-based innovation in the interests of industry and society in Switzerland.<\/p><\/div><\/div>\n\n\n\n

2018 | Capital increase \u2013 loan conversion executed<\/h4>
<\/span><\/div><\/div>

Loan conversion of the seed round investment into equity.<\/p><\/div><\/div>\n\n\n\n

2017 | Start of Innosuisse funded First-in-man study<\/h4>
<\/span><\/div><\/div>

Clinical trial on ZuriMED\u2019s first product, the BTB-Converter\u2122 was approved by Swissethics and sponsored by Innosuisse (formerly Commission for Technology and Innovation in Switzerland [CTI]).<\/p><\/div><\/div>\n\n\n\n

2016 | Seed round investment received<\/h4>
<\/span><\/div><\/div>

Investment in terms of convertible loan. ZuriMED moves into the newly opened Balgrist Campus.<\/p><\/div><\/div>\n\n\n\n

2015 | Incorporation of ZuriMED Technologies AG<\/h4>
<\/span><\/div><\/div>

Winner of Venture Kick Final, Switzerland\u2019s largest start-up acceleration program. Presenting 2nd best business plan by >>venture>>, the leading competition for entrepreneurs in Switzerland, a joint initiative of ETH Zurich, McKinsey & Company, Knecht Holding, Innosuisse and EPFL.<\/p><\/div><\/div>\n\n\t<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
\n
\n

BTB-Converter\u2122<\/h2>\n\n\n\n

Knee ligament reconstruction<\/strong><\/p>\n\n\n\n

Eight years of advanced biomaterial research and translational development at the University and ETH Z\u00fcrich, in collaboration with leading Swiss surgeons, has led to ZuriMED\u2019s Bone-Tendon-Bone (BTB)-Converter\u2122 for knee ligament reconstruction.<\/p>\n\n\n\n

This technology was developed by ZuriMED in the past and has now been out-licensed.<\/p>\n\n\n\n

\"\"<\/figure>\n<\/div>\n\n\n\n
\n

VariLoop\u2122<\/h2>\n\n\n\n

Superior ligament fixation<\/strong><\/p>\n\n\n\n

The single-strand VariLoop\u2122 enables superior ligament fixation. It is simple, easy to use, self-flipping, and truly knotless. The technology\u2019s high reliability and strength have been proven under all testing conditions. This implant can be used in various configurations for many indications where tension or compression is critical for healing.<\/p>\n\n\n\n

This technology was developed by ZuriMED in the past and has now been out-licensed.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Team The core of ZuriMED is built by its people. Our interdisciplinary and diverse team is backed by a strong board of directors comprised of world-renowned experts. Together, we aim to push the boundaries of current orthopedic and sports medicine solutions through our innovative technologies. Our Board of Directors is comprised of world-leading scientists, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1591","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/pages\/1591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/comments?post=1591"}],"version-history":[{"count":5,"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/pages\/1591\/revisions"}],"predecessor-version":[{"id":1605,"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/pages\/1591\/revisions\/1605"}],"wp:attachment":[{"href":"https:\/\/zurimed.com\/eu\/wp-json\/wp\/v2\/media?parent=1591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}